Telomir Pharma Announces Peer-Reviewed Publication Of Preclinical Data Showing Telomir-Zn Produced Dose-Dependent Survival Improvement Across Multiple Endpoints In Wilson's Disease Model
Telomir Pharmaceuticals Inc TELO
$1.29
▲ +0.78%
(+$0.01)
Open
$1.27
Prev Close
$1.28
Day Range
$1.25 – $1.30
52W Range
$1.05 – $3.10
Market Cap
$88.03M
Beta
0.68
EPS (TTM)
$-0.29
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-02-09 |
| Shares Out. | 68,770,000 |
| Website | telomirpharma.com/ ↗ |
| Phone | 17863966723 |
Telomir Pharmaceuticals Inc is a publicly traded company under the ticker symbol TELO on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.